Latest California Healthline Stories
Dentistry Advocates Aim To Fill Medicare Gaps
Brushing aside a political climate that favors federal cuts in health care spending, advocates for oral health are pushing to expand Medicare to provide America’s elderly with dental benefits.
$89,000 Orphan Drug Gets A New Owner — And Likely A New Price
Marathon, maker of an expensive treatment for Duchenne muscular dystrophy, sells the drug for $140 million in cash and stock to PTC Therapeutics.
Universal Health Coverage In California: Is It Even Possible?
On Southern California Public Radio, California Healthline Senior Correspondent Chad Terhune discusses the prospects for coverage-for-all proposals by gubernatorial hopeful Gavin Newsom and others given GOP plans in Washington D.C.
Obamacare Pushed Nonprofit Hospitals To Do Good Beyond Their Walls. Now What?
A provision in the 2010 health law required these hospitals to justify their tax exemption by demonstrating involvement in community health. Repeal, replace or repair could stall that momentum.
Experimental Stem Cell Treatment Leaves Three Women Blind
Researchers, who detail the women’s experiences in the New England Journal of Medicine, say it exposes the need for better regulation of clinical trials.
Health Exchange Enrollment Misses Obama Administration’s Goal, But Stays Steady
Federal officials said 12.2 million people signed up for plans this year on the health law’s marketplaces, down slightly from 2016.
Where You Live May Determine How You Die. Oregon Leads The Way.
A state with integrated systems for end-of-life care offers better treatment for the seriously ill, according to a new study.
Many Californians Could Be Priced Out Of Exchange Coverage, Analysis Finds
California’s health insurance exchange released an analysis showing that Republicans’ plan to trim subsidies, on average, by 40% would fall hard on elderly and very low-income people, especially in expensive areas like San Francisco.
By The Numbers: Trump’s Choice For FDA Chief Is Versatile And Entrenched In Pharma
The numbers show that President Trump’s choice for FDA commissioner, Scott Gottlieb, has long-standing ties to pharmaceutical companies as a board member or consultant and that he had to recuse himself multiple times while working at the FDA.
Americans Not Sold On Cost And Coverage Claims In GOP’s Health Bill
Nearly half of the people in this month’s Kaiser Family Foundation tracking poll believe the Republican legislation will increase the number of uninsured Americans and increase coverage costs.